THIS IS WORLDHEART
Our mission is to save, extend, and enhance the lives of patients suffering from late-stage heart failure.
WorldHeart Corporation is:
- A developer of mechanical circulatory support systems based in Salt Lake City, Utah USA. WorldHeart's registered office is in Delaware, USA.
- Developing innovative, implantable next-generation heart assist pumps such as the hockey-puck size Levacor™ VAD rotary pump for adults who suffer from late-stage heart failure. Designed to provide long-term and full circulatory support, the Levacor VAD is powered by a unique, proprietary, magnetic levitation technology. A U.S. clinical trial to assess the Levacor VAD as a bridge-to-transplant was started in January 2010.
- Developing two miniaturized implantable rotary pumps, each the size of a AA battery: 1) the MIVAD™ for adults with earlier-stage heart failure who need long-term partial cardiac support. The MIVAD blood pump is derived from 2) the Pediaflow™ VAD for newborns and infants with congenital heart defects and other heart ailments. The PediaFlow VAD has been under development with support from the U.S. National Institutes of Health.
- Building on the foundation of more than two decades of supporting heart failure patients with the pioneering first-generation Novacor® LVAS: one of only two such electrically powered pulsatile pumps commercialized in North America, Europe and Japan. The legacy of this pulsatile assist pump was multi-year circulatory support to more than 1,800 heart failure patients both as a bridge and alternative to heart transplant.
THAT'S WORLDHEART... TECHNOLOGY for LIFE